Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Extreme Makeover: Clinical Trials Edition

Posted on December 4th, 2017 by in Pharma R&D

In a piece featured in the PharmaTimes, Katrina Megget points out the sad state of affairs when it comes to clinical trials, highlighting some appalling stats on the frequent failure to reach enrollment targets (in some cases, not finding any patients at all) and the tendency for studies to go on far longer than anticipated. Continue reading “Extreme Makeover: Clinical Trials Edition” »

Big Data vs. Infectious Disease

Posted on October 20th, 2017 by in Pharma R&D

With the many highly effective vaccines that have been created over the last several decades, it can be easy (particularly for those in America and other developed countries) to fall into the trap of thinking that we are living in a world where infectious disease is not that big of a threat. Continue reading “Big Data vs. Infectious Disease” »

Pharma Companies United By a Need for Common Data Models

Posted on October 18th, 2017 by in Pharma R&D

There is nothing that pharmaceutical companies guard more fiercely than their intellectual property. Devising and patenting the next big wonder drug is every company’s dream Continue reading “Pharma Companies United By a Need for Common Data Models” »

Snakes (aka Chutes) and Ladders – failures and opportunities

Posted on October 13th, 2017 by in Pharma R&D

If there ever was a children’s game that would help prepare the next generation of pharmaceutical R&D scientists and researchers, it would be Snakes and Ladders (Chutes and Ladders in the US). Continue reading “Snakes (aka Chutes) and Ladders – failures and opportunities” »

  1. 1
  2. 2
  3. 3
  4. 5